company background image
THQM logo

Tchaikapharma High Quality Medicines AD BUL:THQM Stock Report

Last Price

лв17.30

Market Cap

лв1.5b

7D

0.6%

1Y

8.9%

Updated

12 Jun, 2024

Data

Company Financials

Tchaikapharma High Quality Medicines AD

BUL:THQM Stock Report

Market Cap: лв1.5b

THQM Stock Overview

Engages in the development and manufacture of generic and in-licensed medicines in Bulgaria.

THQM fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends0/6

Tchaikapharma High Quality Medicines AD Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Tchaikapharma High Quality Medicines AD
Historical stock prices
Current Share Priceлв17.30
52 Week Highлв17.40
52 Week Lowлв15.80
Beta0.054
1 Month Change0%
3 Month Change0.58%
1 Year Change8.86%
3 Year Change27.14%
5 Year Change94.68%
Change since IPO627.06%

Recent News & Updates

Recent updates

Is Tchaikapharma High Quality Medicines AD (BUL:7TH) A Risky Investment?

Jan 20
Is Tchaikapharma High Quality Medicines AD (BUL:7TH) A Risky Investment?

Can You Imagine How Elated Tchaikapharma High Quality Medicines AD's (BUL:7TH) Shareholders Feel About Its 317% Share Price Gain?

Dec 10
Can You Imagine How Elated Tchaikapharma High Quality Medicines AD's (BUL:7TH) Shareholders Feel About Its 317% Share Price Gain?

Shareholder Returns

THQMBG PharmaceuticalsBG Market
7D0.6%2.3%-0.3%
1Y8.9%18.5%16.3%

Return vs Industry: THQM underperformed the BG Pharmaceuticals industry which returned 18.5% over the past year.

Return vs Market: THQM underperformed the BG Market which returned 16.3% over the past year.

Price Volatility

Is THQM's price volatile compared to industry and market?
THQM volatility
THQM Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement5.1%
Market Average Movement4.9%
10% most volatile stocks in BG Market8.2%
10% least volatile stocks in BG Market1.9%

Stable Share Price: THQM has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine THQM's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1999199n/awww.tchaikapharma.com

Tchaikapharma High Quality Medicines AD engages in the development and manufacture of generic and in-licensed medicines in Bulgaria. The company offers anaesthetic, anti-inflammatory and anti-rheumatic, antibiotic, cardiovascular system, digestive system, diabetes and metabolism, nervous system, OTC, respiratory system, oncology, and other medicines. It also provides nutritional supplements.

Tchaikapharma High Quality Medicines AD Fundamentals Summary

How do Tchaikapharma High Quality Medicines AD's earnings and revenue compare to its market cap?
THQM fundamental statistics
Market capлв1.54b
Earnings (TTM)лв2.93m
Revenue (TTM)лв48.26m

525.2x

P/E Ratio

31.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
THQM income statement (TTM)
Revenueлв48.26m
Cost of Revenueлв8.80m
Gross Profitлв39.47m
Other Expensesлв36.54m
Earningsлв2.93m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.033
Gross Margin81.77%
Net Profit Margin6.06%
Debt/Equity Ratio9.2%

How did THQM perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.